After The Stock Fell -12.97% Over The Week, Is ImmunityBio Inc (NASDAQ: IBRX) Still A Buy?
ImmunityBio Inc (NASDAQ:IBRX)’s traded shares stood at 4.62 million during the last session, with the company’s beta value hitting 1.10. At the close of trading,